Medical Privacy and Medical Research — Judging the New Federal Regulations

George J. Annas

New England Journal of Medicine · 2002 · 71 citations · 4 references

DOIFull text

Open access

Concepts

TL;DR

Americans value both medical record privacy and research, yet the HIPAA‑based regulations aimed at protecting privacy—though not intended to affect research—have sparked strong objections from biotech and academic medicine. The regulations have elicited strong objections from the biotechnology industry and academic medicine. No additional metadata or code links are provided.

Abstract

Americans support both protecting the privacy of medical records and encouraging medical research. Thus, it is not surprising that a move to change practices in these two areas has generated attention and comment. The new federal regulations, promulgated under the authority of the Health Insurance Portability and Accountability Act of 1996 (HIPAA), were adopted to protect the privacy of medical records. They were not specifically designed to facilitate or limit medical research.1 Nonetheless, the regulations have prompted strong objections from the biotechnology industry and from academic medicine. The Association of American Medical Colleges and the Biotechnology Industry Organization have argued . . .

References

4